These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11524946)

  • 1. [Ribosomal antibiotics].
    Man'kin AS
    Mol Biol (Mosk); 2001; 35(4):597-609. PubMed ID: 11524946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance.
    Skripkin E; McConnell TS; DeVito J; Lawrence L; Ippolito JA; Duffy EM; Sutcliffe J; Franceschi F
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3550-7. PubMed ID: 18663023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding site of macrolide antibiotics on the ribosome: new resistance mutation identifies a specific interaction of ketolides with rRNA.
    Garza-Ramos G; Xiong L; Zhong P; Mankin A
    J Bacteriol; 2001 Dec; 183(23):6898-907. PubMed ID: 11698379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activities of telithromycin, linezolid, and quinupristin-dalfopristin against Streptococcus pneumoniae with macrolide resistance due to ribosomal mutations.
    Farrell DJ; Morrissey I; Bakker S; Buckridge S; Felmingham D
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3169-71. PubMed ID: 15273142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to linezolid caused by modifications at its binding site on the ribosome.
    Long KS; Vester B
    Antimicrob Agents Chemother; 2012 Feb; 56(2):603-12. PubMed ID: 22143525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Context-Specific Action of Ribosomal Antibiotics.
    Vázquez-Laslop N; Mankin AS
    Annu Rev Microbiol; 2018 Sep; 72():185-207. PubMed ID: 29906204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging new generation of antibiotic: ketolides.
    Zhong P; Shortridge V
    Curr Drug Targets Infect Disord; 2001 Aug; 1(2):125-31. PubMed ID: 12455409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotics and the ribosome.
    Tenson T; Mankin A
    Mol Microbiol; 2006 Mar; 59(6):1664-77. PubMed ID: 16553874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrolide myths.
    Mankin AS
    Curr Opin Microbiol; 2008 Oct; 11(5):414-21. PubMed ID: 18804176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and mechanistic basis for translation inhibition by macrolide and ketolide antibiotics.
    Beckert B; Leroy EC; Sothiselvam S; Bock LV; Svetlov MS; Graf M; Arenz S; Abdelshahid M; Seip B; Grubmüller H; Mankin AS; Innis CA; Vázquez-Laslop N; Wilson DN
    Nat Commun; 2021 Jul; 12(1):4466. PubMed ID: 34294725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemistry of peptidyltransferase center-targeted antibiotics: enzymatic resistance and approaches to countering resistance.
    McCusker KP; Fujimori DG
    ACS Chem Biol; 2012 Jan; 7(1):64-72. PubMed ID: 22208312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA.
    Douthwaite S; Hansen LH; Mauvais P
    Mol Microbiol; 2000 Apr; 36(1):183-93. PubMed ID: 10760175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding site of the bridged macrolides in the Escherichia coli ribosome.
    Xiong L; Korkhin Y; Mankin AS
    Antimicrob Agents Chemother; 2005 Jan; 49(1):281-8. PubMed ID: 15616307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrolide antibiotic interaction and resistance on the bacterial ribosome.
    Poehlsgaard J; Douthwaite S
    Curr Opin Investig Drugs; 2003 Feb; 4(2):140-8. PubMed ID: 12669373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance mutations in 23 S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center.
    Kloss P; Xiong L; Shinabarger DL; Mankin AS
    J Mol Biol; 1999 Nov; 294(1):93-101. PubMed ID: 10556031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action.
    Kannan K; Mankin AS
    Ann N Y Acad Sci; 2011 Dec; 1241():33-47. PubMed ID: 22191525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective protein synthesis by ribosomes with a drug-obstructed exit tunnel.
    Kannan K; Vázquez-Laslop N; Mankin AS
    Cell; 2012 Oct; 151(3):508-20. PubMed ID: 23101624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial ribosomal subunit synthesis: a novel antibiotic target.
    Champney WS
    Curr Drug Targets Infect Disord; 2001 May; 1(1):19-36. PubMed ID: 12455231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The macrolide binding site on the bacterial ribosome.
    Poehlsgaard J; Douthwaite S
    Curr Drug Targets Infect Disord; 2002 Mar; 2(1):67-78. PubMed ID: 12462154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Context-specific action of macrolide antibiotics on the eukaryotic ribosome.
    Svetlov MS; Koller TO; Meydan S; Shankar V; Klepacki D; Polacek N; Guydosh NR; Vázquez-Laslop N; Wilson DN; Mankin AS
    Nat Commun; 2021 May; 12(1):2803. PubMed ID: 33990576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.